We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App





PerkinElmer Exhibits Automated Nucleic Acid Extraction Solutions at MEDLAB Middle East

By LabMedica International staff writers
Posted on 26 Jan 2022
Print article
Image: LabChip GX Touch Nucleic Acid Analyzer (Photo courtesy of PerkinElmer, Inc.)
Image: LabChip GX Touch Nucleic Acid Analyzer (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer, Inc. (Waltham, MA; USA) demonstrated its range of automated nucleic acid extraction solutions at the 2022 edition of MEDLAB Middle East held at the Dubai World Trade Centre (DWTC) from January 24 to 27.

PerkinElmer demonstrated its high-throughput Vanadis NIPT solution which takes all the complexity out of cell-free DNA (cfDNA) testing, making it accessible to more women – and more cost-effective for laboratories. This breakthrough technology eliminates PCR amplification and gene sequencing, making it so easy to use that one laboratory technician can handle 2000 to 20,000 samples per year. Walkaway automation streamlines the process from primary tube to final results. Because the Vanadis system is an easy to use, non-NGS and non-PCR based method, any laboratory can use it. Also on display was the LabChip GX Touch nucleic acid analyzer with microfluidic technology that allows DNA and RNA quantitation and sizing to be done in seconds using automated capillary electrophoresis separation.

In addition, PerkinElmer highlighted the chemagic Prepito instrument which is based on the company’s proven technology for magnetic bead based DNA/RNA isolation and represents a top quality sample preparation system available as a compact benchtop instrument. The innovative instrument realizes cost effectiveness through automated dispensing of buffers into standard plastic devices instead of using expensive pre-filled cartridges. It includes barcode reading to provide comfort and to support highest quality assurance demands. Hands-on time is minimized and the processing time is as short as 30 minutes for up to 12 samples per batch.

PerkinElmer also displayed the VICTOR Nivo multimode microplate reader, now with Alpha technology, which packs all popular detection modes into the industry’s smallest multimode reader footprint. The perfect microplate reader for everyday biochemical and cell-based assays, it measures at any wavelength, with top and bottom reading of all standard technologies (top only reading for Alpha). Among other instruments, PerkinElmer exhibited the DELFIA Xpress platform which has been developed to streamline workflows in laboratories and clinics providing prenatal screening services. The platform offers a variety of benefits critical for operational efficiency, and with a wide range of available kits it supports different strategies in aneuploidy and pre-eclampsia screening.

Related Links:
PerkinElmer, Inc. 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.